Aardvark Therapeutics (AARD) Q2 2025 Earnings

14MayConfirmed
Q2 2025
-0.71
-0.7
-0.69
-0.67

Details

Expected EPS
-0.673333
Actual EPS
-0.71
Surprise EPS
-0.04
Surprise Percent
+5.45%

Description

Aardvark Therapeutics (AARD) has reported earnings of -0.71 per share for Q2 2025.

0 Comments

Share your thoughts